Stomach adenocarcinoma (STAD) is one of the most common malignant tumors worldwide.
In this study, we attempted to construct a valid immune-associated gene prognostic index …

Simple Summary Colorectal cancer (CRC) has been divided into four consensus molecular
subtypes (CMS) using the unsupervised clustering of bulk transcriptomic data. The CMS …

Simple Summary The poor prognosis outcome of patients with KRAS mutations (KRAS mut)
was correlated with an immunosuppressive tumor microenvironment (TME). At the gene …

The tumor immune microenvironment plays a vital role in the metastasis of colorectal cancer.
As one of the most important immune cells, macrophages act as phagocytes, patrol the …

The immune microenvironment has profound impacts on the initiation and progression of
colorectal cancer (CRC). Therefore, the goal of this article is to identify two robust immune …

Rectal cancer (RC) is the leading cause of tumor-related death among both men and
women. The efficacy of immunotherapy for rectal cancer is closely related to the immune …

Background Rat sarcoma viral oncogene homolog (RAS) gene mutation is a common
molecular event in colorectal cancer (CRC). The prognosis of mCRC (metastatic colorectal …

The phenotype of tumor-associated macrophages may be critical for tumor immunity,
angiogenesis, and clinical disease outcome. Here, we elucidated the prognostic …

Colorectal cancer (CRC) is one of the most frequent and deadly forms of cancer. About half
of patients are affected by metastasis, with the cancer spreading to eg, liver, lungs or the …

The immune tumor microenvironment (TME) of colorectal cancer (CRC) is a crucial
contributor to disease biology, making it an important target for therapeutic intervention. The …